Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome
Aim. To assess nebivolol clinical effects on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. In total, 21 patients were administered nebivolol (5 mg/d) for one month. Dynamics of anthropometry parameters, lipid profile, p...
Saved in:
| Main Author: | I. N. Medvedev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-02-01) -
Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2006-10-01) -
Increased intravascular platelet activity in metabolic syndrome patients, and its correction by simvastatin treatment
by: N. I. Gromnatsky, et al.
Published: (2004-12-01) -
HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016-01-01) -
Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
by: I. N. Medvedev, et al.
Published: (2007-06-01)